PPARG and chronic obstructive pulmonary disease: Moreover, recent in vivo studies confirm that the modulation of PPAR-γ activity in the lung can influence inflammatory and immune response in endotoxemia [34] and in other pulmonary diseases, such as COPD and asthma [35].